loadpatents
name:-0.0096449851989746
name:-0.040404081344604
name:-0.0069999694824219
Sloan; Kenneth B. Patent Filings

Sloan; Kenneth B.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Sloan; Kenneth B..The latest application filed is for "vitamin c prodrugs and uses thereof".

Company Profile
0.23.3
  • Sloan; Kenneth B. - Gainesville FL
  • Sloan; Kenneth B. - Eudora KS
  • Sloan; Kenneth B. - Lawrence KS
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Vitamin C prodrugs and uses thereof
Grant 9,550,744 - Sloan January 24, 2
2017-01-24
Vitamin C Prodrugs And Uses Thereof
App 20160264541 - Sloan; Kenneth B.
2016-09-15
Polymerized Sunscreen Absorbers
App 20140227212 - Wagener; Kenneth B. ;   et al.
2014-08-14
Prodrugs of biologically active hydroxyaromatic compounds
Grant 5,001,115 - Sloan March 19, 1
1991-03-19
Prodrugs of 6-mercaptopurine and 6-mercaptopurine ribosides and therapeutic compositions and methods employing them
Grant 4,443,435 - Bodor , et al. April 17, 1
1984-04-17
Mannich-base hydroxamic acid prodrugs, compositions and use
Grant 4,412,994 - Sloan , et al. November 1, 1
1983-11-01
Soft tertiary amine esters of bio-affecting carboxylic acids
Grant 4,381,307 - Sloan April 26, 1
1983-04-26
Pyridylmethyl esters of selected bio-affecting carboxylic acids
Grant 4,376,767 - Sloan March 15, 1
1983-03-15
Novel sypathomimetic amine prodrugs
Grant 4,313,956 - Bodor , et al. February 2, 1
1982-02-02
Novel dopa/dopamine prodrugs
Grant 4,311,706 - Bodor , et al. January 19, 1
1982-01-19
Prodrugs for the improved delivery of halogen-containing glucocorticosteroids
Grant 4,279,900 - Bodor , et al. July 21, 1
1981-07-21
Transient pro-drug forms of xanthine derivatives and their use as topical anti-inflammatory agents
Grant 4,275,064 - Bodor , et al. * June 23, 1
1981-06-23
Prodrugs for improved bioavailability of certain .DELTA..sup.4 -3-ketosteroidal sex hormones
Grant 4,268,441 - Bodor , et al. May 19, 1
1981-05-19
5,5-Diphenylhydantoins
Grant 4,260,769 - Stella , et al. April 7, 1
1981-04-07
Esteramide prodrugs of anti-inflammatory corticosteroids
Grant 4,221,787 - Bodor , et al. September 9, 1
1980-09-09
Anti-acne and anti-seborrhea prodrug derivatives of progesterone
Grant 4,213,978 - Bodor , et al. July 22, 1
1980-07-22
Prodrugs for the improved delivery of non-steroidal anti-inflammatory agents
Grant 4,206,220 - Sloan June 3, 1
1980-06-03
Derivatives of 5,5-diphenylhydantoin exhibiting enhanced solubility and the therapeutic use thereof
Grant 4,163,058 - Stella , et al. July 31, 1
1979-07-31
Pro-drugs for the improved delivery of certain selected anti-inflammatory steroids
Grant 4,069,322 - Bodor , et al. January 17, 1
1978-01-17
N-Nicotinoyl-3,4-dinicotinoyloxy-L-phenylalanine and derivatives pharmaceutical compositions and methods containing same
Grant 4,065,566 - Bodor , et al. December 27, 1
1977-12-27
Treating psoriasis with transient pro-drug forms of xanthine derivatives
Grant 4,061,753 - Bodor , et al. December 6, 1
1977-12-06
Novel, transient pro-drug forms of L-DOPA to treat Parkinson's disease
Grant 4,035,507 - Bodor , et al. July 12, 1
1977-07-12
Novel, transient pro-drug forms of L-DOPA
Grant 3,998,799 - Bodor , et al. December 21, 1
1976-12-21
Novel, transient pro-drug forms of l-dopa useful in the treatment of parkinson's disease
Grant 3,939,253 - Bodor , et al. February 17, 1
1976-02-17
Novel, transient pro-drug forms of l-dopa
Grant 3,891,696 - Bodor , et al. June 24, 1
1975-06-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed